缺氧诱导因子2α 抗体

缺氧诱导因子2α 抗体产品标准

浓缩液(1mg/1ml) 亲和纯化抗体

产品应用

WB=1:100-500 Elisa =1:200-1000 IP=1:20-100 IHC=1:100-500 （石蜡切片需做抗原修复）

缺氧诱导因子2α 抗体产品说明

HIF-2α也是机体对缺氧适应性调节中的重要调控蛋白.有学者认为：HIF-2α对肿瘤的能量代谢和新血管生成有促进作用,微血管的形成可抑制肿瘤细胞的凋亡,从而促进肿瘤的恶性发展。
Transcription factor involved in the induction of ozkgen regulated genes. Binds to core DNA sequence 5'-[AG]CGTG-3' within the hypoxia response element (HRE) of target gene promoters. Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation requires recruitment of transcriptional coactivators such as CREBPB and probably EP300. Interaction with redox regulatory protein APEX seems to activate CTAD. Also known as Hypoxia-inducible factor -2α; Hypoxia-inducible factor 2 alpha; HIF-2 alpha; Endothelial PAS domain-containing protein 1; EPAS-1; HIF-1 alpha-like factor; MHLF; HIF-related factor; HRF; MOP2; Hif2a.
[SUBUNIT] Efficient DNA binding requires dimerization with another bHLH protein. Heterodimerizes with ARNT. Interacts with CREBPB.
[SUBCELLULAR LOCATION] Nucleus (Potential).
[TISSUE SPECIFICITY] Expressed in most tissues, with highest levels in lung, followed by heart, kidney, brain and liver. Predominantly expressed in endothelial cells. Also found in smooth muscle cells of the uterus, neurons, and brown adipose tissue. High expression in embryonic choroid plexus and kidney glomeruli.
[DEVELOPMENTAL STAGE] In day 11 embryo, expression is almost exclusively seen in endothelial cells of the intersegmental blood vessels separating the somites, the atrial and ventricular chambers of the heart, and the dorsal aorta. High expression also occurs in extraembryonic membranes. In the developing brain of day 13 embryo, endothelial cells of the highly vascularized choroid plexus contain high levels of EPAS1.
[PTM] In normoxia, is probably hydrozklated on Pro-405 and Pro-530 by EGLN1/PHD1, EGLN2/PHD2 and/or EGLN3/PHD3. The hydrozklated prolines promote interaction with VHL, initiating rapid ubiquitination and subsequent proteasomal degradation. Under hypoxia, proline hydrozklation is impaired and ubiquitination is attenuated, resulting in stabilization (By similarity).
[PTM] In normoxia, is hydrozklated on Asn-851 by HIF1AN thus probably abrogating interaction with CREBBP and EP300 and preventing transcriptional activation.
[ PTM] Phosphorylated on multiple sites in the CTAD.
[PTM] The iron and 2-oxoglutarate dependent 3-hydrozklation of asparagine is (S) stereospecific within HIF CTAD domains.
[SIMILARITY] Contains 1 basic helix-loop-helix (bHLH) domain.
[SIMILARITY] Contains 1 PAC (PAS-associated C-terminal) domain.
[SIMILARITY] Contains 2 PAS (PER-ARNT-SIM) domains

zk-13704R Uroplakin Ia尿路上皮特异蛋白1a抗体
zk-13829R USP16去泛素酶16抗体
zk-13738R URP2整合素结合性信号分子抗体
zk-3464R Phospho-ATG1(Ser556)磷酸化自噬相关蛋白1抗体
zk-0230R FGFR1碱性成纤维细胞生长因子受体1抗体
zk-1935R Uteroglobin子宫珠蛋白抗体
zk-1929R Urocortin尿皮质素抗体
zk-9145R UBOX5泛素结合酶7相互作用蛋白5抗体
zk-1936R USP1泛素特异性蛋白酶1抗体
zk-1925R UCP-1线粒体脱偶连蛋白1抗体
zk-1926R UCP-2线粒体脱偶连蛋白2抗体
zk-1934R UCP-3线粒体脱偶连蛋白3抗体
zk-11675R UBXD2UBX结构域域蛋白D2抗体
zk-11676R UCHL3泛素硫酯酶L3抗体
zk-11677R UCHL1+3泛素硫酯酶L1+3抗体
zk-11776R UBE3A人乳头状瘤病毒E6相关蛋白抗体
zk-8383R UBE2Q1泛素蛋白连接酶Q1抗体
zk-8384R UBE2U泛素蛋白连接酶U抗体
zk-8369R Ube2L6泛素载体蛋白L6抗体
zk-8370R Ube2H泛素激活酶2H抗体
zk-8371R Ube2G1泛素蛋白连接酶G1抗体
zk-8373R UBE2E1泛素蛋白连接酶E1抗体
zk-8352R UBE2E3泛素蛋白连接酶E3抗体
zk-8353R UBE2E2泛素蛋白连接酶2E2抗体
zk-8354R UBE2D4泛素蛋白连接酶D4抗体
zk-8355R UBE2D3泛素蛋白连接酶D3抗体
zk-8356R UBE2D1泛素蛋白连接酶D1抗体
zk-8357R UBE2C泛素蛋白连接酶C抗体
zk-8347R SUMO-1泛素蛋白连接酶E2I抗体
缺氧诱导因子2α 抗体